Expression and Purification of Natural N-Terminal Recombinant Bovine Pancreatic Trypsin Inhibitor from Pichia pastoris

  • Yang Lili
    Department of Immunology, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital
  • Dong Wen
    Department of Orthopaedic Surgery, Tianjin Medical University First Central Hospital
  • He Jinchao
    Department of Biochemistry, College of Pharmacy, Jilin University
  • Ren Xiubao
    Department of Immunology, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital
  • Yan Weiqun
    Department of Biochemistry, College of Pharmacy, Jilin University

Search this article

Abstract

Bovine pancreatic trypsin inhibitor (BPTI) is a natural non-specific serine protease inhibitor and possesses the ability to inhibit trypsin, chymotrypsin, plasmin and plasma kallikrein. The expression of BPTI in Escherichia coli and other systems has been reported. However, the preparation of recombinant BPTI (rBPTI) with correct N-terminus in Pichia pastoris has not been successful. A previous study showed that the preBPTI with the prepro leader sequence of alpha mating factor (AMF) was not processed into natural BPTI in P. pastoris. Now, we introduce a new method to prepare rBPTI, which carries a natural N-terminal amino acid residue, Arg-Pro-Asp, in P. pastoris using human serum albumin signal peptide corresponding to the pre sequence. The concentration of rBPTI in an 80 l fermentor reached 900 mg/l. We also explored a rapid and simple purification protocol for rBPTI and the purity of rBPTI reached 95—98% as evaluated by SDS-PAGE analysis. The sequencing results showed that the sequence of N-terminal 15 amino acids of rBPTI was consistent with that of natural BPTI. The inhibitory activity of rBPTI against trypsin was the same as natural BPTI and its Ki was 2.6±0.1×10−9. The therapeutic effect of rBPTI on acute pancreatitis was identified in rats.

Journal

References(39)*help

See more

Details 詳細情報について

Report a problem

Back to top